Traffic:
10E
10W
15N
15S
57N
57S
60E
60W
210E
210W
This Site
Web Search
powered by
YAHOO! SEARCH
Subscriber Services
|
Home Delivery
|
e-Edition
|
Alerts
|
RSS
Home
News
Ontario
Rancho Cucamonga
Pomona
Upland
Claremont
Montclair
Chino Valley
California
Crime & Public Safety
Elections
Education
S.B. County Watch
Upland Watch
I.E.: Medicare Testing Ground
Sports
Buy Event Tickets Now
Golf - Tee Times and Courses
Preps
Reign Hockey
Rancho Cucamonga Quakes
Local Colleges
USC
UCLA
Lakers
Clippers
Dodgers
Angels
Ducks
Soccer
Motor Sports
Horse Racing
Live Odds
Business
Autos
Real Estate News
Technology
Opinions
Editorial
Letters
Columnists
Blogs
LA.COM
Buy Tickets
Movies
TV
Music
Shopping & Beauty
Recreation
Neighborhood
Arts
Living
Dining
Find A Restaurant
Lottery
Horoscopes
Travel
Trevor's Travels
Health
Crossword Puzzle
Local Casinos
Foothills Magazine
Info
Subscribe For Home Delivery
Contact Us
RSS
Podcast
Subscriber Services
Place An Ad
NIE
Classified
Place an Ad
Homes
Jobs
Auto
Search autos
Buy/Sell a car
Research/Financing a car
Find a dealer
Shopping
This week's ads
Obits
Directories
Local Business
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about ADAP
Recent news which mentions ADAP
< Previous
1
2
3
Next >
Adaptimmune Agrees To Merge With Another Cell Therapy Focused Company
March 06, 2023
Tickers
ADAP
TCRR
Tags
News
Briefs
Earnings
From
Benzinga
Why Is TCR2 Therapeutics (TCRR) Stock Up 30% Today?
March 06, 2023
Tickers
ADAP
TCRR
Tags
TCRR
Market News
NASDAQ:TCRR,NASDAQ:ADAP
From
InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
March 06, 2023
Tickers
ACRS
ADAP
ARMP
BBIO
Tags
VTVT
Benzinga
BBIO
From
Benzinga
Adaptimmune Therapeutics's Earnings Outlook
March 03, 2023
Tickers
ADAP
Tags
BZI/EP
Earnings
Market News
From
Benzinga
NXP Semiconductors, UBS Group And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
January 31, 2023
Tickers
ADAP
BBAI
HLIT
LCID
Tags
MU
Markets
UBS
From
Benzinga
Expert Ratings for Adaptimmune Therapeutics
January 05, 2023
Tickers
ADAP
Tags
Analyst Ratings
Market News
BZI/AAR
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
January 05, 2023
Tickers
ADAP
ADPT
ALLO
ALLY
Tags
JWN
OLN
RVLV
From
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
December 30, 2022
Tickers
ADAP
ALR
BNTC
BXRX
Tags
Benzinga
ALR
FNCH
From
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
December 30, 2022
Tickers
ADAP
ALR
BNTC
BXRX
Tags
ADAP
SLRX
BXRX
From
Benzinga
Credit Suisse, Autodesk And Other Big Losers From Wednesday
November 25, 2022
Tickers
ADAP
ADSK
AENZ
ANGO
Tags
Markets
PAGS
GRND
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 9, 2022
November 09, 2022
Tickers
ADAP
ADCT
AMRS
BLDR
Tags
LITE
GTN
RE
From
Benzinga
Why Party City Holdco Shares Tumbled Over 40%; Here Are 98 Biggest Movers From Yesterday
November 09, 2022
Tickers
AAON
ADAP
AEL
AGRX
Tags
DBGI
NCLH
SSP
From
Benzinga
Why Adaptimmune Therapeutics Stock Is Glowing Green Today
November 08, 2022
Tickers
ADAP
Tags
Recent Press Releases
ADAP
Market News
From
Motley Fool
12 Health Care Stocks Moving In Tuesday's Intraday Session
November 08, 2022
Tickers
ADAP
ALLK
ATHX
ATIP
Tags
Movers
ADAP
ALLK
From
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
October 25, 2022
Tickers
ADAP
AVGR
DBVT
ENSC
Tags
NMTC
REVB
UHS
From
Benzinga
GSK Transfers Cell Therapy Program Rights To Adaptimmune, Terminates Second Cell Therapy Pact In A Day
October 25, 2022
Tickers
ADAP
GSK
Tags
Health Care
Biotech
Large Cap
From
Benzinga
Domino's Pizza To $385? Plus This Analyst Cuts Price Target On Adaptimmune Therapeutics By Around 79%
October 04, 2022
Tickers
ADAP
CCL
CLNN
DPZ
Tags
PGR
Markets
ADAP
From
Benzinga
Important Biotech Catalysts For September 9, 2022 - End Of The Day Summary
September 09, 2022
Tickers
ADAP
ALLK
ARQT
AZN
Tags
SPPI
IMCR
News
From
Benzinga
Adaptimmune's Cancer Candidate Shows 44% Response Rate In Pretreated Ovarian, Urothelial, Head & Neck Cancers
September 09, 2022
Tickers
ADAP
Tags
Penny Stocks
Benzinga
Market News
From
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
September 09, 2022
Tickers
ADAP
AKLI
ALLK
ANVS
Tags
ATXI
ADAP
BGXX
From
Benzinga
Adaptimmune Therapeutics: Q2 Earnings Insights
August 04, 2022
Tickers
ADAP
Tags
Benzinga
ADAP
BZI/Recaps
From
Benzinga
Biotech Daily: Amgen, Gilead Go Shopping, Nod For AstraZeneca's Lynparza In Early Stage Breast Cancer, Decision Day For Alzheimer's Associated Hallucinations Candidate
August 04, 2022
Tickers
ABUS
ACAD
ADAP
AGIO
Tags
TVTX
Market News
VRTX
From
Benzinga
Got $500? 3 Absurdly Cheap Healthcare Stocks That Are Set to Skyrocket
July 01, 2022
Tickers
ADAP
AXSM
GTHX
Tags
ADAP
Recent Press Releases
GTHX
From
Motley Fool
Why Adaptimmune Therapeutics Stock Is Popping Today
June 27, 2022
Tickers
ADAP
EPZM
IPSEY
Tags
Recent Press Releases
ADAP
IPSEY
From
Motley Fool
69 Biggest Movers From Friday
June 06, 2022
Tickers
ACOR
ADAP
AEYE
AMLX
Tags
NX
HARP
RUBY
From
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
June 03, 2022
Tickers
ADAP
AVTX
BGXX
CRIS
Tags
CRIS
RLYB
YMTX
From
Benzinga
Adaptimmune Therapeutics's Return On Capital Employed Insights
June 03, 2022
Tickers
ADAP
Tags
ADAP
Benzinga
Earnings
From
Benzinga
Why Shares of Adaptimmune Therapeutics Rose 13.4% on Tuesday
May 17, 2022
Tickers
ADAP
RHHBY
Tags
Market News
ADAP
RHHBY
From
Motley Fool
12 Health Care Stocks Moving In Monday's After-Market Session
May 16, 2022
Tickers
ACER
ADAP
ADIL
ADMP
Tags
Market News
ACER
EPZM
From
Benzinga
Adaptimmune Therapeutics: Q1 Earnings Insights
May 09, 2022
Tickers
ADAP
Tags
ADAP
Benzinga
Market News
From
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Privacy Policy
|
Terms of Use
|
MNG Corporate Site Map
|
Copyright